Please login to the form below

Not currently logged in
Email:
Password:

Lupin

This page shows the latest Lupin news and features for those working in and with pharma, biotech and healthcare.

Biogen files Tecfidera follow-up in the US

Biogen files Tecfidera follow-up in the US

Earlier this month Indian drugmakers Lupin Labs and Shilpa Medicare both won tentative FDA approval for generic dimethyl fumarate capsules, although they have not indicated when they intend to place the

Latest news

More from news
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    165. Shionogi (JP). Kyowa (JP) (Lupin). Asset acquisition Japan. 21 branded products in Japan with $90m sales.

  • Pharma deals in July 2015 Pharma deals in July 2015

    The consolidation in the generics industry has also increased with Lupin's acquisition of the US generics company Gavis for $880m at a high sales multiple of nine but which has ... In July Lupin also acquired a factory in Russia and a speciality product

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Minoyrx Therapeutics appoints chief medical officer Minoyrx Therapeutics appoints chief medical officer

    Dr Uwe Meya joins from Lupin Atlantis Holdings. Spanish orphan disease specialist Minoryx Therapeutics has appointed Dr Uwe Meya as its new chief medical officer. ... He joins the Barcelona-based drug development company from Lupin Atlantis Holdings,

  • Lupin appoints Thierry Volle president for EMEA Lupin appoints Thierry Volle president for EMEA

    He moves to the company from Vifor. Mumbai-based pharma company Lupin has appointed Thierry Volle to lead its Europe, Middle-East and Africa operations as president. ... Vinita Gupta, Lupin's chief executive officer, said: "We are delighted to have

  • Dr Maurice Chagnaud appointed as new CEO of Polpharma Dr Maurice Chagnaud appointed as new CEO of Polpharma

    He will join the company next week from Lupin where he was a group president with an inhalation remit for Europe, Russia &CIS. ... We are impressed by the extensive experience of Mr Chagnaud, gained in international companies such as Merck Generics, Teva

  • Lupin names chief corporate development officer Lupin names chief corporate development officer

    Theresa Stevens has experience at Novartis and Aptalis. Lupin has appointed Theresa Stevens as chief corporate development officer for its global operations. ... Lupin's decision to hire Stevens follows its appointment earlier this year of Teva's Dr

  • Lupin appoints European president Lupin appoints European president

    countries. He will also be responsible for developing Lupin's core strategy for inhalation across all developed markets. ... Prior to joining Lupin, Dr Chagnaud was senior VP, Central and Eastern Europe, at Israel-based Teva.

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics